Andrea Park
Fortune : - $ au 30/04/2026
Fortune : - $ au 30/04/2026
Ms. Andrea E.
Park was previously employed as a Chief Financial Officer by AlphaTON Capital Corp., a Chief Financial Officer by AgeX Therapeutics, Inc., a Vice President-Finance & Controller by Lineage Cell Therapeutics, Inc., and a Chief Financial & Accounting Officer by Serina Therapeutics, Inc. She received her undergraduate degree from the University of California.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COMPUTE CORP -.--% | 21/07/2025 | 0 ( -.--% ) | - $ | 30/04/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Directeur Financier/CFO | 24/10/2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2019 |
| AGEX THERAPEUTICS, INC. | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
AlphaTON Capital Corp.
AlphaTON Capital Corp. BiotechnologyHealth Technology Operates as an immuno oncology company | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Zonebourse is also available in this country: United States.
Switch edition